Artigo de periodico

Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis (2018)

• Authors:
  • Arruda, Lucas C. M.
  • Lima-Júnior, João R.
  • Clave, Emmanuel
  • Moraes, Daniela A.
  • Douay, Corinne
  • Fournier, Isabelle
  • Moins-Teisserenc, Hélène
  • Covas, Dimas Tadeu
  • Simões, Belinda Pinto
  • Farge, Dominique
  • Toubert, Antoine
  • Farias, Kelen Cristina Ribeiro Malmegrim de
  • Oliveira, Maria Carolina
• USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; SIMOES, BELINDA PINTO - FMRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; ARRUDA, LUCAS COELHO MARLIÉRE - FMRP ; LIMA JÚNIOR, JOÃO RODRIGUES - FCFRP ; MORAES, DANIELA APARECIDA DE - FMRP
• Unidades: FMRP; FCFRP
• DOI: 10.1038/s41409-018-0162-0
• Subjects: TRANSPLANTE AUTÓLOGO; CÉLULAS-TRONCO; BIOMARCADORES
• Agências de fomento:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Financiado pelo INSERM
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
    Processo FAPESP: 2014/20922-2
  • Financiado por CEPID-FAPESP
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2018
• Source:
  • Título: Bone Marrow Transplantation
  • ISSN: 0268-3369
  • Volume/Número/Paginação/Ano: v. 53, n. 10, p. 1319-1327, 2018


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui acesso gratuito no site do editor (Bronze Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  ARRUDA, Lucas C. M. et al. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, v. 53, n. 10, p. 1319-1327, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41409-018-0162-0. Acesso em: 31 mar. 2026.

• APA

  Arruda, L. C. M., Lima-Júnior, J. R., Clave, E., Moraes, D. A., Douay, C., Fournier, I., et al. (2018). Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, 53( 10), 1319-1327. doi:10.1038/s41409-018-0162-0

• NLM

  Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41409-018-0162-0

• Vancouver

  Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41409-018-0162-0

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients
• Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
• Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients
• Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation
• Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
• New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
• Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
• Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
• Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
• Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy